This Buprenorphine Waiver Training is offered through the joint providership of Provider's Clinical Support System (PCSS), American Academy of Addiction Psychiatry (AAAP), Maryland Primary Care Program, and Central East ATTC.
Location: Taneytown Public Library, 10 Grand Dr, Taneytown, MD 21787
Presenter: Kyle Kampman, MD
At the conclusion of this activity participants should be able to:
Screen and identify patients with OUD and define evidence-based treatments.
Discuss the pharmacology of opioids as it relates to treatment of opioid use disorder (OUD) patients.
Describe the fundamentals of office-based opioid treatment including the treatment of the co-morbid patient.
Explain the process of buprenorphine induction as well as stabilization and maintenance.
Discuss all FDA approved antagonist and agonist medications to treat OUD.
Discuss basic office protocols including medical record documentation and confidentially.
Utilize evidence-based resources to ensure providers have the confidence to prescribe buprenorphine for patients with OUD.
Recognize the importance of obtaining a waiver to begin treating patients with OUD.
Note: Residents may take the course and apply for their waiver when they receive their DEA license. They will need to maintain their certificate of completion following the training.
Contact: email@example.com or 240-645-1145
For more information about this initiative and SAMHSA-sponsored training opportunities, sign up for the Buprenorphine Waiver Management email list.